Venture
Avalyn Pharma Inc.
Latest Form D 2023-10-10- CIK 1540171
- State MA
- Biotechnology
- 4 Form D offerings since 2012-11-16
- Total sold
- $245M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2012-11-16
- Latest round
- $189M
- 2023-10-10 · 021-494182
- Investors
- 26
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2023-10-10 · $189M
- 2012-11-16$2.2M021-187115
- 2017-03-24$18.2M021-283266
- 2020-05-08$35.5M021-366535
- 2023-10-10$189M021-494182
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($189M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-494182 | First filed2023-10-10 | Latest2023-10-10 | Sought$189M | Sold$189M | Investors26 | Exemptions506(b) |
| 021-366535 | First filed2020-05-08 | Latest2020-05-08 | Sought$35.7M | Sold$35.5M | Investors8 | Exemptions506(b) |
| 021-283266 | First filed2017-03-24 | Latest2017-05-24 | Sought$64.9M | Sold$18.2M | Investors46 | Exemptions506(b) |
| 021-187115 | First filed2012-11-16 | Latest2015-08-12 | Sought$2.2M | Sold$2.2M | Investors41 | Exemptions506(b) |
Who backs Avalyn Pharma Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-10-10
| Name | Relationship |
|---|---|
| Lyn Baranowski | RelationshipExecutive Officer, Director |
| Jonathan Leff | RelationshipDirector |
| Peter Moldt | RelationshipDirector |
| Niall O'Donnell | RelationshipDirector |
| Ketan Patel | RelationshipDirector |
| Tiba Aynechi | RelationshipDirector |
| Cassandra Gianna Luca | RelationshipDirector |
| Jill Carroll | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b)
- First filed
- 2012-11-16
- Latest filing
- 2023-10-10
Who backs Avalyn Pharma Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗